Doximity (NYSE:DOCS) Raised to Moderate Buy at Needham & Company LLC

Doximity (NYSE:DOCS) was upgraded by stock analysts at Needham & Company LLC to a “moderate buy” rating in a research note issued on Friday,Zacks.com reports.

DOCS has been the subject of several other reports. Barclays upgraded Doximity to a “strong-buy” rating in a research report on Monday, December 8th. The Goldman Sachs Group raised Doximity from a “strong sell” rating to a “hold” rating in a research note on Friday, January 9th. Wall Street Zen lowered Doximity from a “buy” rating to a “hold” rating in a research report on Saturday, January 10th. Royal Bank Of Canada raised Doximity to a “moderate buy” rating in a report on Thursday, January 8th. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of Doximity in a research note on Wednesday, December 24th. Three analysts have rated the stock with a Strong Buy rating, three have given a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of $55.00.

Doximity Trading Down 16.7%

Shares of NYSE:DOCS opened at $27.76 on Friday. The stock has a market capitalization of $5.23 billion, a PE ratio of 23.13, a PEG ratio of 1.29 and a beta of 1.39. Doximity has a fifty-two week low of $23.66 and a fifty-two week high of $85.21.

Doximity Company Profile

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.